The EQ Score shows the company's activity and appeal on the platform: profile completeness, news, likes, follows, membership in one or more labels or communities, number of members in its network, etc.
An innovative diagnostic medical device company striving to aid ophthalmologists in the fight against ocular hypertension and glaucoma induced blindness by providing continuous intraocular pressure fluctuation data for 24 hours.
Istanbul, Istanbul, Turkey
Send a message
We’ve been named one of Hello Tomorrow's Deep Tech Pioneers! Selected among more than 5,000 startups from 128 different countries that applied to the Global Challenge. Come and meet us at the Hello Tomorrow Global Summit in Paris on 12th-13th March 2020!
We are proud to announce that our SME Instrument Phase 1 proposal has been awarded this competitive and prestigious grant from the European Community. Our ESR score of 13.91 placed us 89th among the 3275 apllications filed in the last cut-off. This project will enable GlakoLens to conduct an in-depth technical and economic feasibility study culminating into an updated business plan focusing on global commercialization of our innovative technology.
The proprietary technology of GlakoLens will provide ophthalmologists with a powerful diagnostic tool, GlakoSense Platform, in the fight against glaucoma induced blindness. We are foreseeing a future where an early diagnosis of ocular hypertension will prevent deterioration of quality of life due to sight loss and consequent economic and social burden on societies.